Myocardial "hybrid" revascularisation with minimally invasive direct coronary artery bypass grafting combined with coronary angioplasty: preliminary results of a multicentre study

Por Wittwer, T, Cremer, J, Boonstra, P, Grandjean, J, Mariani, M, Mugge, A, Drexler, H, den Heijer, P, Leitner, E, Hepp, A, Wehr, M, Haverich, A
Publicado em 2000

Antiplatelet therapy in patients undergoing coronary stenting: The risk of late stent thrombosis

Por ten Berg, J.M., van Werkum, J.W., Heestermans, A.A.C.M., Jaarsma, W., Hautvast, R.M.A., den Heijer, P., de Boer, M.J.
Publicado em 2006

Recommendations for the use of bioresorbable vascular scaffolds in percutaneous coronary interventions: 2017 revision

Por Everaert, B., Wykrzykowska, J. J., Koolen, J., van der Harst, P., den Heijer, P., Henriques, J. P., van der Schaaf, R., de Smet, B., Hofma, S. H., Diletti, R., Weevers, A., Hoorntje, J., Smits, P., van Geuns, R. J.
Publicado no Neth Heart J (2017)

Antithrombotic therapy in patients undergoing TAVI: an overview of Dutch hospitals

Por Nijenhuis, V. J., Stella, P. R., Baan, J., Brueren, B. R. G., de Jaegere, P. P., den Heijer, P., Hofma, S. H., Kievit, P., Slagboom, T., van den Heuvel, A. F. M., van der Kley, F., van Garsse, L., van Houwelingen, K. G., van’t Hof, A. W. J., ten Berg, J. M.
Publicado em 2013